Karakuş, F. Et Al. 2025. Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction. CURRENT COMPUTER-AIDED DRUG DESIGN , vol.21, no.3 , 348-361.

Karakuş, F., Kuzu, B., Köstekci, S., & Tülüce , Y., (2025). Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction. CURRENT COMPUTER-AIDED DRUG DESIGN , vol.21, no.3, 348-361.

Karakuş, Fuat Et Al. "Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction," CURRENT COMPUTER-AIDED DRUG DESIGN , vol.21, no.3, 348-361, 2025

Karakuş, Fuat Et Al. "Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction." CURRENT COMPUTER-AIDED DRUG DESIGN , vol.21, no.3, pp.348-361, 2025

Karakuş, F. Et Al. (2025) . "Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction." CURRENT COMPUTER-AIDED DRUG DESIGN , vol.21, no.3, pp.348-361.

@article{article, author={Fuat Karakuş Et Al. }, title={Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction}, journal={CURRENT COMPUTER-AIDED DRUG DESIGN}, year=2025, pages={348-361} }